Veracyte Earnings
NASDAQ: VCYTHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$0.28
Veracyte earnings summary
Veracyte is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $0.28. In its most recent report on Jul 31, 2026 (Q2 2026), VCYT posted EPS of $0.31. Revenue for the quarter was $150.3 million.
Across the last 16 reports, VCYT shares moved an average of 7.5% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
VCYT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 31, 2026 | — | $0.31 | — | +1.9% |
| May 6, 2026 | — | $0.35 | — | -4.8% |
| Feb 26, 2026 | — | $0.50 | — | -7.5% |
| Nov 5, 2025 | — | $0.24 | — | -5.6% |
| Aug 7, 2025 | — | $-0.01 | — | +10.4% |
| May 8, 2025 | — | $0.09 | — | -1.7% |
| Feb 28, 2025 | — | $0.07 | — | -7.9% |
| Nov 7, 2024 | — | $0.19 | — | -1.5% |
| Aug 7, 2024 | — | $0.07 | — | +12.2% |
| May 8, 2024 | — | $-0.02 | — | +7.1% |
| Feb 29, 2024 | — | $-0.38 | — | -5.3% |
| Nov 8, 2023 | — | $-0.41 | — | +13.7% |
| Aug 9, 2023 | — | $-0.12 | — | -1.4% |
| May 5, 2023 | — | $-0.11 | — | +1.0% |
| Mar 1, 2023 | — | $-0.06 | — | -14.8% |
| Nov 3, 2022 | — | $-0.12 | — | +22.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.